Literature DB >> 2871099

Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.

D C Shanson, M Tadayon.   

Abstract

Teicoplanin had greater inhibitory activity than vancomycin against most of 22 penicillin tolerant strains of streptococci, but both drugs failed to kill 99.9% of the inoculum when tested alone at concentrations less than 16mg 1(-1). Bactericidal synergy between teicoplanin combined with gentamicin and vancomycin combined with gentamicin was always demonstrated in further tests with 16 penicillin tolerant strains. Teicoplanin had greater bactericidal activity than vancomycin against five of seven strains of viridans streptococci and five of nine strains of enterococci in MBC experiments, where each drug was combined with gentamicin. Killing curve experiments with five penicillin tolerant streptococci showed teicoplanin and vancomycin to have similar bactericidal activity within 24 h when tested at 5 mg 1(-1) with 2 mg 1(-1) gentamicin. However, at 0.5 mg 1(-1) only teicoplanin had a bactericidal synergic effect with gentamicin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871099     DOI: 10.1016/0195-6701(86)90009-5

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

2.  In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.

Authors:  J H Jorgensen; L A Maher; J S Redding
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

Review 3.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.

Authors:  M J Rybak; S A Lerner; D P Levine; L M Albrecht; P L McNeil; G A Thompson; M T Kenny; L Yuh
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.